Polarean Imaging (LON:POLX) Stock Price Up 14.8% – Should You Buy?

Polarean Imaging plc (LON:POLXGet Free Report) traded up 14.8% on Tuesday . The stock traded as high as GBX 1.05 ($0.01) and last traded at GBX 1.05 ($0.01). 89,608 shares traded hands during trading, a decline of 96% from the average session volume of 2,407,660 shares. The stock had previously closed at GBX 0.92 ($0.01).

Polarean Imaging Stock Performance

The firm has a fifty day simple moving average of GBX 1.23 and a 200 day simple moving average of GBX 1.20. The company has a current ratio of 4.12, a quick ratio of 9.80 and a debt-to-equity ratio of 2.61. The stock has a market cap of £14.40 million, a price-to-earnings ratio of -0.25 and a beta of 0.38.

About Polarean Imaging

(Get Free Report)

Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function.

Recommended Stories

Receive News & Ratings for Polarean Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarean Imaging and related companies with MarketBeat.com's FREE daily email newsletter.